ICoVVaC_CohortC_3months_postdose4
Networks
-
Variables
-
Population
ICoVVaC - Cohort C
The population is composed of cancer patients with solid tumours from cancer clinics at the Ottawa Hospital and at Vancouver BC Cancer, who were on chemotherapy and who are going to receive COVID-19 vaccination as part of the national vaccine roll-out (standard of care) and included in the study within 4 weeks of the second dose of vaccine.
Data Collection Event
ICoVVaC - Cohort C - 3 months post-dose 4
Information on vaccine information and assessment of clinical outcomes (incidence of COVID-19) was collected.
Blood (serum and peripheral blood mononuclear cells (PBMCs) samples were collected.